Richard Otto, MD
Urology · Milwaukee, WINPI 1487913513
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $563 of the $685 with a category attached, or 82.3%. It is spread thinly across 14 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in WI, where the typical reported total is $673.
Across 33 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$134
- AbbVie$122
- Coloplast$88
- Endo Pharmaceuticals Inc.$62
- Neotract Inc.$49
- Progenics Pharmaceuticals, Inc.$42
- plus $188 from 8 others
What the payments were for
- Food & beverage$56382%
- Education$12218%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $134 |
| AbbVie | 7 | $122 |
| Coloplast | 6 | $88 |
| Endo Pharmaceuticals Inc. | 3 | $62 |
| Neotract Inc. | 2 | $49 |
| Progenics Pharmaceuticals, Inc. | 1 | $42 |
| Novo Nordisk | 2 | $41 |
| Endo USA, Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $24 |
| Procept Biorobotics Corporation | 1 | $23 |
| Accord Healthcare, Inc. | 1 | $23 |
| Cook Medical LLC | 1 | $17 |
| Immunitybio, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
How this compares
$685 in reported general payments places this provider in the 50th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 52 | $40,415 |
| Tamsulosin Hcl | 276 | $3,403 |
| Solifenacin Succinate | 83 | $3,069 |
| Finasteride | 191 | $2,168 |
| Tolterodine Tartrate ErTolterodine Tartrate | 17 | $1,831 |
| Estradiol | 11 | $819 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $649 |
| Trospium Chloride | 13 | $548 |
| Oxybutynin Chloride ErOxybutynin Chloride | 36 | $537 |
| Oxybutynin Chloride | 30 | $414 |
| Bicalutamide | 15 | $339 |
| NitrofurantoinNitrofurantoin Macrocrystal | 15 | $319 |
| Cephalexin | 23 | $234 |
| Ciprofloxacin Hcl | 35 | $217 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 55 | $154 |
Paid to pharmacies, not to this prescriber.
Other urology in Milwaukee
- Amy GuiseMilwaukee$106K
- Mark WaplesMilwaukee$15K
- Robert OconnorMilwaukee$12K
- Matthew JohnsonMilwaukee$10K
- Peter LeonoviczMilwaukee$9K
- Arjun SivaramanMilwaukee$8K
- Graham MachenMilwaukee$7K
- Scott JohnsonMilwaukee$6K
- Luriel Smith-HarrisonMilwaukee$5K
- Charles KiddMilwaukee$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.